CMAB BioPharm

About:

CMAB BioPharm is a Biopharmaceutical Service Firm.

Website: http://www.cmabbio.com/

Top Investors: Qianhai Fund of Funds, CD Capital, Cormorant Capital, C-Bridge Capital, Jinqiao Capital

Description:

CMAB BioPharm is a Biopharmaceutical Service Firm. Suqiao Bio is a flexible, comprehensive biopharmaceutical custom development and production (CDMO) service company. Strictly in compliance with the quality standards of domestic and international pharmaceutical production management regulations, Suqiao Bio is committed to providing Chinese and global customers with a one-stop shop for preclinical and clinical drug Phase I, Phase II, and Phase III biopharmaceutical products from DNA sequences to commercial production. solution.

Total Funding Amount:

$72M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2017-01-01

Contact Email:

hello(AT)cmabbio.com

Founders:

Qibin Liang

Number of Employees:

11-50

Last Funding Date:

2018-04-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai